Immediate confirmation of adenosine diphosphate P2Y12 receiver detection set - Taiwan Registration 4f81dfc589916d7fdcf819750953ea89
Access comprehensive regulatory information for Immediate confirmation of adenosine diphosphate P2Y12 receiver detection set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4f81dfc589916d7fdcf819750953ea89 and manufactured by ACCUMETRICS, INC.. The authorized representative in Taiwan is MEDDRAGON TECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Paired with an immediate confirmation analyzer to measure the blockade of the platelet P2Y12 receiver. Confirm Now The Adenucleoside Diphosphate P2Y12 Receptor Assay is a whole blood test that can be used in the laboratory or point-of-care unit to measure platelet P2Y12 receptor blockade. Intended Use: To identify patients with high residual platelet activity (HRPR) or who respond poorly to a high risk of future cardiovascular events.
B Hematology, pathology, and genetics
B.5700 Automated platelet agglutination system
import
Dates and Status
Apr 14, 2011
Apr 14, 2016
May 17, 2018
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ